Science Over Stigma: Why Legislators Must Embrace Tobacco Harm Reduction
October 02, 2026 by protectingtaxpayers.org
Science Over Stigma: Why Legislators Must Embrace Tobacco Harm Reduction
The text argues that growing evidence supports tobacco harm reduction products, especially e-cigarettes, as alternatives for adult smokers. It cites a Cochrane review of nine trials finding vaping more effective than traditional nicotine replacement therapies for quitting, with no serious harms identified in those trials. It also describes FDA authorization of reduced-risk marketing claims for ZYN nicotine pouches. The author contends that restrictive policies discourage cessation and fuel illicit markets, while cigarette smoking causes substantial mortality and economic costs. The text urges clinicians and policymakers to prioritize scientific evidence over stigma and prohibition, arguing that access to lower-risk nicotine products could improve public health.
